The role of contactin-associated protein-like 2 in neurodevelopmental disease and human cerebral cortex evolution

The contactin-associated protein-like 2 gene is associated with multiple neurodevelopmental disorders, including autism spectrum disorder (ASD), intellectual disability (ID), and specific language impairment (SLI). Experimental work has shown that is important for neuronal development and synapse fo...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in molecular neuroscience Vol. 15; p. 1017144
Main Authors St George-Hyslop, Frances, Kivisild, Toomas, Livesey, Frederick J
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 20.10.2022
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The contactin-associated protein-like 2 gene is associated with multiple neurodevelopmental disorders, including autism spectrum disorder (ASD), intellectual disability (ID), and specific language impairment (SLI). Experimental work has shown that is important for neuronal development and synapse formation. There is also accumulating evidence for the differential use of in the human cerebral cortex compared with other primates. Here, we review the current literature on , including what is known about its expression, disease associations, and molecular/cellular functions. We also review the evidence for its role in human brain evolution, such as the presence of eight human accelerated regions (HARs) within the introns of the gene. While progress has been made in understanding the function(s) of , more work is needed to clarify the precise mechanisms through which acts. Such information will be crucial for developing effective treatments for patients. It may also shed light on the longstanding question of what makes us human.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Reviewed by: J. Peter H. Burbach, University Medical Center Utrecht, Netherlands; Davide Comoletti, Victoria University of Wellington, New Zealand
This article was submitted to Brain Disease Mechanisms, a section of the journal Frontiers in Molecular Neuroscience
Edited by: Michel J. Simonneau, École Normale Supérieure Paris-Saclay, France
ISSN:1662-5099
1662-5099
DOI:10.3389/fnmol.2022.1017144